Podcast Episodes
Back to Search
Strengthening the Generic Drugs Supply Chain
Natalie de Graaf, from the API Innovation Center, discusses a recent whitepaper detailing areas where the generic drugs pipeline is under stress.
2 weeks ago
Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial
In today's Pharmaceutical Executive Daily, Bayer agrees to acquire Perfuse Therapeutics for up to $2.45 billion and Madrigal obtains an exclusive glo…
2 weeks ago
Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results
In today's Pharmaceutical Executive Daily, Cellenkos announces FDA clearance of its investigational new drug application for CK0802, BioNTech release…
2 weeks, 1 day ago
Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics
In today's Pharmaceutical Executive Daily, UCB announces a definitive agreement to acquire Candid Therapeutics for up to $2.2 billion, a new commenta…
2 weeks, 2 days ago
Pharmaceutical Executive Daily: FDA Approves Auvelity
In today's Pharmaceutical Executive Daily, the FDA's Oncologic Drugs Advisory Committee votes a favorable benefit-risk profile for AstraZeneca's Truq…
2 weeks, 5 days ago
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO
In today’s Pharmaceutical Executive Daily, Sanofi formally confirms its CEO leadership following a shareholder vote, US prescription drug spending is…
2 weeks, 6 days ago
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher
In today's Pharmaceutical Executive Daily, Rocket Pharmaceuticals announces a $180 million sale of its rare pediatric disease priority review voucher…
3 weeks ago
Pharmaceutical Executive Daily: FDA Approves Breztri
In today's Pharmaceutical Executive Daily, we cover Sun Pharma and IMG Pharma's respective acquisitions, FDA's approval of AstraZeneca's Breztri, and…
3 weeks, 1 day ago
Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia
In today's Pharmaceutical Executive Daily, Eli Lilly announces a definitive agreement to acquire Ajax Therapeutics for up to $2.3 billion, adding a f…
3 weeks, 2 days ago
Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie
In today’s Pharmaceutical Executive Daily, the FDA issues a complete response letter to AbbVie for a biologics license application, Regeneron moves t…
3 weeks, 5 days ago